Zevra Therapeutics (ZVRA) Q3 2024 Earnings

13AugConfirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
-0.48
-0.37
-0.26
-0.15

Details

Expected EPS
-0.454
Actual EPS
-0.48
Surprise EPS
-0.03
Surprise Percent
+5.73%

Description

Zevra Therapeutics (ZVRA) has reported earnings of -0.48 per share for Q3 2024.

0 Comments

Share your thoughts